Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Chuikyo OKs NHI Price Listing of 14 APIs/15 Products
November 20, 2014
-
REGULATORY 3 Straight Years of NHI Price Cuts Loom as Abe Delays Sales Tax Hike, Eyes Now Turned to 2019 and Beyond
November 19, 2014
-
REGULATORY Health Ministry Drug Evaluation Head Calls for Mulling Necessity of PI Studies for Japanese Patients
November 18, 2014
-
REGULATORY PMDA to Accept All Requests for Generic Drug Face-to-Face Consultations
November 17, 2014
-
BUSINESS Combined Half-Year Sales of Major Japanese Drug Makers Up 2.8% Thanks to Overseas Sales
November 14, 2014
-
REGULATORY New Japan NIH Head Asks Pharma Industry to Suggest Ideas for Benefit of Japanese People
November 13, 2014
-
BUSINESS Generic Makers Back on Growth Track in First Half of FY2014
November 12, 2014
-
BUSINESS Kowa Looks to Triple Eye Drug Business with Glanatec
November 11, 2014
-
BUSINESS Feburic Grabs Top Slot for GP Market in September “Mind Share” Ranking
November 10, 2014
-
BUSINESS Meiji Seika Pharma Poised to Get Lion’s Share in Antidepressant Market
November 10, 2014
-
BUSINESS Sales of Four Major Wholesalers Hit by Drop in Long-Listed Product Sales
November 7, 2014
-
REGULATORY Sept. Drug Price Settlement Rate at 92.6% as Big Hospitals, Pharmacies Take Quantum Leap
November 6, 2014
-
BUSINESS Overseas Growth Boosts Combined Sales of Four Major Drug Makers
November 6, 2014
-
TRENDS Chugai Led in Research Grants Payment in FY2013; Grants Fell Among Major Drug Makers
November 5, 2014
-
BUSINESS Astellas’s First-Half Sales Rise 9.3%, Operating Profit 61.8%
November 4, 2014
-
BUSINESS Takeda Aims for Consecutive Sales Growth through FY2022
October 31, 2014
-
BUSINESS GPCR Consortium, an International Partnership of Industry and Academia, Established: Ono
October 30, 2014
-
ORGANIZATION JPMA to Launch Compound Library Joint Purchasing Initiative; Full-Scale Purchasing to Begin in FY2015
October 29, 2014
-
BUSINESS Pfizer Japan Gearing Up for Reorganization in December, Pres. Umeda to Double as Head of New Unit
October 28, 2014
-
BUSINESS Japan Arm of Hengrui Medicine Files Campto Generic for Approval
October 27, 2014
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…